Matthew Kirkpatrick to Double-Blind Method
This is a "connection" page, showing publications Matthew Kirkpatrick has written about Double-Blind Method.
Connection Strength
1.158
-
Effects of non-tobacco flavors and nicotine on e-cigarette product appeal among young adult never, former, and current smokers. Drug Alcohol Depend. 2019 10 01; 203:99-106.
Score: 0.126
-
Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels. J Clin Psychopharmacol. 2015 Jun; 35(3):308-12.
Score: 0.094
-
Prosocial effects of MDMA: A measure of generosity. J Psychopharmacol. 2015 Jun; 29(6):661-8.
Score: 0.093
-
MDMA: a social drug in a social context. Psychopharmacology (Berl). 2015 Mar; 232(6):1155-63.
Score: 0.090
-
MDMA effects consistent across laboratories. Psychopharmacology (Berl). 2014 Oct; 231(19):3899-905.
Score: 0.087
-
Effects of MDMA and Intranasal oxytocin on social and emotional processing. Neuropsychopharmacology. 2014 Jun; 39(7):1654-63.
Score: 0.086
-
In the company of others: social factors alter acute alcohol effects. Psychopharmacology (Berl). 2013 Nov; 230(2):215-26.
Score: 0.082
-
Personality and the acute subjective effects of d-amphetamine in humans. J Psychopharmacol. 2013 Mar; 27(3):256-64.
Score: 0.080
-
Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction. 2012 Apr; 107(4):783-91.
Score: 0.076
-
Effects of intranasal methamphetamine on metacognition of agency. Psychopharmacology (Berl). 2008 Mar; 197(1):137-44.
Score: 0.056
-
Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing. Neuropsychopharmacology. 2020 04; 45(5):823-832.
Score: 0.033
-
Rewarding effects of physical activity predict sensitivity to the acute subjective effects of d-amphetamine in healthy volunteers. J Psychopharmacol. 2018 03; 32(3):302-308.
Score: 0.028
-
Validation of a behavioral economic purchase task for assessing drug abuse liability. Addict Biol. 2019 03; 24(2):303-314.
Score: 0.028
-
Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults. Psychopharmacology (Berl). 2017 Jan; 234(2):307-315.
Score: 0.026
-
Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: Application of a novel methodology. Drug Alcohol Depend. 2016 Nov 01; 168:176-180.
Score: 0.026
-
Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration. Psychoneuroendocrinology. 2016 12; 74:92-100.
Score: 0.026
-
Asians compared to Whites show increased response to d-amphetamine on select subjective and cardiovascular measures. Pharmacol Biochem Behav. 2016 May; 144:73-7.
Score: 0.025
-
Oxytocin receptor gene variation predicts subjective responses to MDMA. Soc Neurosci. 2016 12; 11(6):592-9.
Score: 0.025
-
Intimate insight: MDMA changes how people talk about significant others. J Psychopharmacol. 2015 Jun; 29(6):669-77.
Score: 0.023
-
'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Soc Cogn Affect Neurosci. 2014 Aug; 9(8):1076-81.
Score: 0.022
-
Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend. 2008 Apr 01; 94(1-3):258-62.
Score: 0.014
-
Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology. 2008 Jul; 33(8):1847-55.
Score: 0.014